KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) EPS (Basic): 2009-2024

Historic EPS (Basic) for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to -$2.15.

  • Pacira BioSciences' EPS (Basic) rose 103.86% to $0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.46, marking a year-over-year increase of 123.35%. This contributed to the annual value of -$2.15 for FY2024, which is 336.26% down from last year.
  • Latest data reveals that Pacira BioSciences reported EPS (Basic) of -$2.15 as of FY2024, which was down 336.26% from $0.91 recorded in FY2023.
  • Over the past 5 years, Pacira BioSciences' EPS (Basic) peaked at $3.41 during FY2020, and registered a low of -$2.15 during FY2024.
  • In the last 3 years, Pacira BioSciences' EPS (Basic) had a median value of $0.35 in 2022 and averaged -$0.30.
  • In the last 5 years, Pacira BioSciences' EPS (Basic) spiked by 1,362.96% in 2020 and then slumped by 336.26% in 2024.
  • Over the past 5 years, Pacira BioSciences' EPS (Basic) (Yearly) stood at $3.41 in 2020, then tumbled by 72.14% to $0.95 in 2021, then slumped by 63.16% to $0.35 in 2022, then spiked by 160.00% to $0.91 in 2023, then plummeted by 336.26% to -$2.15 in 2024.